|
Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified health advice, visits or treatment with a real mD. We are not doctors. Always consult your doctor about Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy Clinical research trials and Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy healthcare trials happen in many of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new drugs. The purpose of the studies / projects is to solve particular human medical questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to discover cures for all varieties of conditions, such as Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy. Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy Clinical Trials and other clinical trials allow volunteers to have health treatment alternatives before they are available to the masses. Some times the human subjects obtain treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy clinical trial. Test subjects oftentimes receive the most effective healthcare possible for their Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy condition. Dangers are a reality, however, and may include extra or frequent physician visits, healthcare dangers (possibly life-jeopardising), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "P" Clinical Trials Conditions > Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy  Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy
Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy
For Condition: Neutropenia,Sarcoma
Status: Recruiting
Sponsor(s): Amgen ,
Synopsis: Physicians are conducting a clinical trial for patients with sarcoma. Sarcoma is a type of bone cancer that can be treated with chemotherapy which can affect the bone marrow, where blood cells are produced. Neutrophils are a type of white blood cells that fight infection and are produced in the bone marrow. If the neutrophil count becomes too low due to chemotherapy, a potentially serious condition called neutropenia occurs. Neutropenia is serious because it can affect the body's ability to protect against many types of infections. Pegfilgrastim is an investigational drug being evaluated for its potential ability to increase the number of neutrophils. The purpose of this study is to determine the safety and effectiveness of pegfilgrastim in preventing neutropenia following chemotherapy in patients up through the age of 11 with sarcoma.
Details:
Eligibility:
Study Type: Interventional, Prevention, Randomized, Open Label, Active Control, Safety/Efficacy Study
Minimum Age/Maximum Age: /11 Years
Genders: Both
Protocol Entry Criteria: - Sarcoma - No previous chemotherapy or radiotherapy - Patients who will be receiving chemotherapy consisting of Vincristine, Doxorubicin, Cyclophosphamide, Etoposide, Ifosfamide, and Mesna
Total Enrollment: 84
Location and Contact Information:
Research Center *Recruiting*
Memphis, Tennessee,
United States
Recruiting
Research Center *Recruiting*
Orange, California,
United States
Recruiting
Research Center *Recruiting*
Little Rock, Arkansas,
United States
Recruiting
Additional Information:
Study ID Numbers: 990130;
Study Start Date: May 2003
Record last reviewed: April 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00035620
Other Neutropenia Studies:
1. Temozolomide and O6-Benzylguanine for Treating Childhood Cancers
2. Treating Inoperable Lung Tumors With Heated Chemotherapy Medicine Delivered Solely to the Lung
3. Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy
4. Magnetic-Targeted Doxorubicin in Treating Patients with Cancer Metastatic to the Liver
5. Phase II Trial of Gleevec (STI571) in Patients with Advanced Soft Tissue or Bone Cancer
Related Studies:
Other Neutropenia Clinical Trials
Other California Clinical Trials
Other Orange Clinical Trials
Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy
|
|
|
|
|
|
|
|
